NOVACYT (ALNOV.PA) Financials
ALNOV.PA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | ? | ? |
2023-06-30 | 153.4 million | 28.8 million |
2023-03-31 | 170.8 million | 32.1 million |
2022-12-31 | 158.9 million | 29.0 million |
ALNOV.PA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | ? | ? |
2023-06-30 | -3.9 million | ? |
2023-03-31 | -3.8 million | ? |
2022-12-31 | -7.7 million | 10820 |
ALNOV.PA Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | ? |
2023-06-30 | -5.6 million |
2023-03-31 | -5.4 million |
2022-12-31 | -10.8 million |
ALNOV.PA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | - |
2023-06-30 | 94.9 million | 254270 | 451649 |
2023-03-31 | 105.7 million | - | - |
2022-12-31 | 98.1 million | 296567 | 983294 |
ALNOV.PA Shares Outstanding
ALNOV.PA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | - | - | - |
2023-06-30 | 93233 | 837079 | 3.8 million | 1.0 million |
2023-03-31 | 89202 | 800883 | 3.6 million | 973471 |
2022-12-31 | 16549 | 1.1 million | 3.2 million | 1.2 million |
ALNOV.PA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 11.0 million | - |
2023-06-30 | 2.3 million | 1.1 million |
2023-03-31 | 2.2 million | 1.1 million |
2022-12-31 | 2.9 million | 2.0 million |
ALNOV.PA
Price: €0.71
52 week price:
Earnings Per Share: -0.42 EUR
P/E Ratio: -1.37
Exchange: PAR
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 43.3 million